PART I Overview We are a preclinical-stage synthetic allogeneic iMSC therapy company. iMSCs are induced pluripotent stem cell (iPSC)-derived mesenchymal stem cells. We envision a future where cell therapies powered by synthetic iMSCs can offer new options for patients with limited treatment paths and our mission is to transform the treatment of cancer and autoimmune disease by developing scalable, affordable, off-the-shelf cell therapies that restore hope. Objectives and Business Strategy Our le...
Q2 FY2026 — expected 2026-07-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-13 | 2025-12-31 | 0001493152-26-010102 | EDGAR | 72K words |
| 2025-03-12 | 2024-12-31 | 0001493152-25-010051 | EDGAR | — |
| 2024-03-14 | 2023-12-31 | 0001140361-24-013254 | EDGAR | — |
| 2023-03-20 | 2022-12-31 | 0001140361-23-012418 | EDGAR | — |
| 2022-04-15 | 2021-12-31 | 0001140361-22-014764 | EDGAR | — |
| 2021-03-11 | 2020-12-31 | 0001493152-21-005827 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001493152-20-004343 | EDGAR | — |
| 2019-03-22 | 2018-12-31 | 0001493152-19-003770 | EDGAR | — |
| 2018-03-09 | 2017-12-31 | 0001493152-18-003164 | EDGAR | — |
| 2017-03-09 | 2016-12-31 | 0001493152-17-002280 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001493152-26-036424 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001493152-25-021287 | EDGAR | 24K words |
| 2025-08-13 | 2025-06-30 | 0001493152-25-011910 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0001641172-25-009044 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001493152-24-044841 | EDGAR | — |
| 2024-08-13 | 2024-06-30 | 0001493152-24-031639 | EDGAR | — |
| 2024-05-14 | 2024-03-31 | 0001140361-24-026010 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0001140361-23-052742 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0001140361-23-039283 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001140361-23-024180 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001140361-22-041399 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001140361-22-029251 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-03-20 | 0001493152-26-011922 | EDGAR | 1K words |
| 2026-02-26 | 0001493152-26-008182 | EDGAR | — |
| 2026-02-11 | 0001493152-26-006227 | EDGAR | — |
| 2025-12-11 | 0001493152-25-027167 | EDGAR | — |
| 2025-07-07 | 0001641172-25-018009 | EDGAR | — |
| 2025-06-12 | 0001641172-25-014877 | EDGAR | — |
| 2025-06-09 | 0001641172-25-014318 | EDGAR | — |
| 2025-06-02 | 0001641172-25-013249 | EDGAR | — |
| 2025-04-03 | 0001641172-25-002514 | EDGAR | — |
| 2025-03-26 | 0001641172-25-000681 | EDGAR | — |
372 total filings indexed. 340 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000748592 |
| Ticker | ERNA |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.ernexatx.com |
| Listed | 2021-03-26 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ERNA (~200 tokens, structured JSON with cryptographic provenance)